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The development of the human nervous system
is an extended process. It begins during early
embryogenesis with the speciﬁcation of neural
epithelium; it requires that complex synaptic
circuits be established [reviewed by Pomeroy
and Kim (2000); Volpe (2000)], and it may
never truly end in that synaptic connections
continue to be modiﬁed throughout life, pre-
sumably as a mechanism of brain information
storage (Black et al. 1998). Therefore, intrusion
of a neurotoxicant could produce different
defects depending on the timing and level of
exposure (Spencer 2000) because it might dis-
rupt populations of neurons engaged in cellular
proliferation, migration, differentiation, or
maturation (Jensen and Catalano 1998; Rodier
1995). This timing issue alone makes assessing
the risk of even a single compound at a single
dose a complex task, even discounting individ-
ual differences in response. Ideally, a biomarker
would assess an important brain function with
broad sensitivity. In this study, we questioned
whether measuring experience-dependent brain
plasticity late in development can reveal subtle
lasting deﬁcits caused by exposure to a neuro-
toxicant early in development.
By late embryogenesis, cortical neurons
have been intrinsically programmed to form
dendrites of the appropriate architecture
(Banker and Waxman 1988). However, den-
drites continue to grow into the postnatal
period (Becker et al. 1984; Juraska 1982) and
remain “plastic,” such that extrinsic factors,
notably, the unique behavioral experience of
the individual, can induce readily quantiﬁable
modiﬁcations in dendritic structure throughout
life [reviewed by Kolb and Whishaw (1998)].
The therapeutic potential of behavioral stimu-
lation is well established (e.g., Walsh and
Greenough 1976), and recent animal studies
demonstrate positive plastic changes in brain
structure or physiology following housing in a
broadly stimulating environment (e.g., Rema
and Ebner 1999) or regimens of training
designed to address speciﬁc functional deﬁcits
(Klintsova et al. 1999). The fact that plasticity
is often reduced (e.g., Rema and Ebner 1999),
or even eliminated after these manipulations
(e.g., Berman et al. 1996), however, suggests
that measurements of plasticity per se could
provide an improved biomarker for detecting
latent neurotoxic damage relevant to lasting
learning and memory deﬁcits.
The environmental complexity (EC) para-
digm, originally devised by Hebb (1947), has
been a key tool in documenting that behavioral
experience produces enduring modiﬁcations of
brain circuitry and behavior throughout life. It
has also been used to identify cellular and
molecular changes associated with the long-
term storage of information in the mam-
malian brain [reviewed by Greenough (1976);
Rosenzweig et al. (1972); van Praag et al.
(2000)]. In this model, litters of rats are
divided into conditions of differential envi-
ronmental stimulation. Rats housed individu-
ally in standard cages (IC) are compared with
their siblings that have been housed as a group
in a complex environment that provides con-
tinuing opportunity for exploration, play, and
spatial learning. Experience in the EC induces
a robust and coordinated growth response in
neurons (Kempermann et al. 1997; Turner and
Greenough 1985; Volkmar and Greenough
1972), as well as in supporting cells (Black et
al. 1987; Jones et al. 1996; Sirevaag and
Greenough 1991). This array of cellular
changes accumulates in some regions of neo-
cortex to the extent that the thickness of cortex
increases signiﬁcantly (Diamond et al. 1964).
In the present study, we have selected this
classic behavioral paradigm to test the hypoth-
esis that cortical plasticity will begin to fail at a
lower neurotoxicant dose than will the gross
maturation of cortex. Our goal was to estab-
lish a laboratory assay for neuroanatomical
plasticity using a summary measure such as
cortical thickness that would be efficient yet
sensitive. Such an assay could then be used to
screen a variety of substances, including mix-
tures such as those found in groundwater sur-
rounding Superfund sites.
As an initial test of this model, we selected
a compound with well-characterized effects on
brain development in rats, methylazoxy-
methanol acetate (MAM), a derivative of the
cycad plant (Spencer et al. 2000). MAM
causes DNA damage, and through this mecha-
nism it is thought to kill actively dividing neu-
rons (Esclaire et al. 1999). When administered
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Millions of children are exposed to low levels of environmental neurotoxicants as their brains are
developing. Conventional laboratory methods of neurotoxicology can detect maldevelopment of
brain structure but are not designed to detect maldevelopment of the brain’s capacity for plasticity
that could impair learning throughout life. The environmental complexity (EC) paradigm has
become classic for demonstrating the modiﬁcations in brain structure that occur in response to expe-
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tested the hypothesis that if degradation of experience-dependent cortical plasticity is used as a bio-
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saline vehicle or 1, 5, 10, or 25 mg/kg of the well-characterized developmental neurotoxicant methy-
lazoxymethanol acetate (MAM) on the 16th or 17th day of gestation. On postnatal days 35–39,
male offspring were assigned to either a complex environment (EC) or an individual cage (IC) for 28
days to stimulate neuroanatomical plasticity. This response was measured as the difference between
the thickness of visual cortex of IC and EC littermates at a given dose. The threshold dose for signiﬁ-
cant reduction of cortical thickness was 25 mg/kg, but the threshold dose for failure of plasticity was
much lower and could be detected at 1 mg/kg, the lowest dose used. No other method of assessment
has detected lasting effects of prenatal exposure to MAM at such a low dose. These data suggest that
this simple test of plasticity could be an efficient way to detect subtle neurotoxic damage to the
developing brain. Key words: biomarker, complex environment, cortical plasticity, developmental
neurotoxicology, methylazoxymethanol. Environ Health Perspect 111:1294–1298 (2003).
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during rat cortical neurogenesis [gestational days
(GDs) 14–18], MAM produces a dose-depen-
dent forebrain microcephaly that is most pro-
nounced at GDs 14–15 (Fischer et al. 1972;
Haddad et al. 1972; Tamaru et al. 1988).
MAM-induced microcephaly has become a
common experimental model for studying corti-
cal dysgenesis (Berger-Sweeney and Hohmann
1997; Colacitti et al. 1999). In addition to
killing some neurons as they are being gener-
ated, prenatal MAM treatment causes detectable
elevations in DNA adducts that remain
detectable at postnatal day (PD) 30 (Kisby et al.
1999) and generates aberrant patterns of con-
nectivity in the remaining cells (Colacitti et al.
1999). We administered MAM on GD 16 or
17 because this exposure a) coincides with the
generation of association neurons in the superﬁ-
cial layers of cortex (Bayer and Altman 1995)
that express robust plasticity (Juraska et al. 1980;
Wallace et al. 1992) and b) produces milder
morphogenic effects than do exposures at GDs
14–15 (e.g., Balduini et al. 1991). We chose a
range of doses based upon data from GD-15
exposures in which the reported threshold dose
for obvious reduction of cortical volume by
MAM is > 10 mg/kg (Fischer et al. 1972;
Haddad et al. 1972; Tamaru et al. 1988) and
the reported threshold dose for behavioral
deficits (e.g., open field, maze training and
avoidance conditioning) is > 15 mg/kg (e.g.,
Balduini et al. 1991; Ohta et al. 2000). A high
dose (25 mg/kg) was included as a positive con-
trol for morphogenic effects, but we focused on
relatively low doses expected to produce a
grossly normal brain (i.e., 1, 5, and 10 mg/kg).
Materials and Methods
Embryonic exposure to MAM. Litters of Long-
Evans hooded rats (Simonsen Laboratories,
Gilroy, CA) were exposed in utero to the neu-
rotoxin MAM (Midwest Research Institute,
Kansas City, MO) on GD 16 or 17 via a sin-
gle intraperitoneal injection to the pregnant
dam. The day of sperm plug detection was
recorded as GD 1.
Timed-pregnant dams were selected ran-
domly to receive 0 (saline vehicle), 1, 5, 10, or
25 mg/kg MAM in saline (12 dams per GD).
For all doses, 2 dams were injected, except 3
dams each received saline or 5 mg/kg MAM
injections on GD 16 and 3 dams each were
injected with 5 mg/kg or 10 mg/kg treatments
on GD 17. Offspring were housed with the
dam until weaning on PD 28 and then housed
in groups of two or three until the start of dif-
ferential housing. Because handling per se can
apparently induce neuroanatomical changes
(Horner et al. 1991), we left rats undisturbed
between weaning and assignment to differen-
tial housing to maximize EC–IC differences.
All animals were handled according to the
guidelines of the National Institutes of Health
Ofﬁce of Laboratory Animal Welfare (2002).
Differential housing. At PDs 35–39, male
littermates were selected randomly for assign-
ment to differential housing conditions, and
these conditions were then balanced for body
weight. Two littermate pairs from each dose
were assigned to differential housing, with the
exception of two litters that produced fewer
than four males (one litter treated with saline,
one litter treated with 25 mg/kg MAM). Rats
were housed either individually in standard lab-
oratory cages (IC) or as a cohort of 12 with the
opportunity to play and explore in a large cage
ﬁlled with toys that were changed daily (EC). As
an additional opportunity for exploration, EC
animals were placed in an open-ﬁeld play cage
with a novel arrangement of toys for 1 hr daily.
All doses of MAM-treated and saline-treated rats
were represented in a single EC cage, such that
two parallel EC environments were required to
accommodate the number of animals involved.
Differential housing was continued in this man-
ner for 28 days. Food and water in both condi-
tions were administered ad libitum. EC and IC
conditions were maintained in the same room
under a 12-hr light/12-hr dark cycle to control
for ambient conditions.
Cortical thickness measures and quantita-
tive analyses. Cortical thickness was used as a
simple, quantitative measure to determine both
the effects of MAM treatment and the effects
of differential housing. At the end of environ-
mental exposure, rats were euthanized [sodium
pentobarbital (Nembutal), 150 mg/kg, intra-
peritoneally], and their brains were removed,
fresh-frozen using isopentane chilled over dry
ice, sectioned into 20 µm coronal sections with a
cryostat, and stained with a Nissl stain. A stan-
dard sample section of occipital cortex (OC) was
approximately –4.3 mm from bregma and iden-
tiﬁed by the presence of both dorsal and ventral
hippocampal formation with a narrowing in the
middle [comparable with Figure 21 from Zilles
(1985)]. The section was scanned to produce a
digital image [Polaroid SprintScan 35+ with
scan path enabler (Polaroid Corporation,
Waltham, MA) using Photoshop 5.5 software
(Adobe Systems Inc., San Jose, CA)]. To correct
for overall differences in brain size that might
arise from toxicant treatment, standard atlas
coordinates for cortical subdivisions within the
sample section (Zilles 1985) and the spacing of
triplicate measures were normalized to the cross-
sectional area of each brain. Cortical thickness
was measured using NIH Image 1.62 software
(National Institutes of Health, Bethesda, MD)
as the distance between the lower boundary of
layer I and the beginning of the white matter
beneath layer VI. All histological processing and
data collection were carried out blind to the
experimental history of the cases.
The average of the three measurements was
analyzed using a general linear model (GLM),
allowing for unequal numbers of subjects, with
dose, housing condition, and GD of dose (GD
16 vs. GD 17) as main effects. Design and
number of animals per condition are reported
in Table 1. Unequal numbers arose because of
the a priori decision to use additional animals
in some conditions (particularly intermediate
doses), low numbers of males in some litters,
and tissue loss during processing. The influ-
ences of dose and housing condition on corti-
cal thickness were assessed using t-statistics for
individual effects estimated from the GLM
(Netter et al. 1989).
Results
Experimental design and main effects. We
exposed the developing rats to a range of
MAM doses via injections to timed-pregnant
01 5 1 0 2 5
MAM dose (mg/kg)
Housing
GD Dose condition No.
16 0 IC 3
16 0 EC 3
16 1 IC 3
16 1 EC 3
16 5 IC 4
16 5 EC 4
16 10 IC 2
16 10 EC 2
16 25 IC 3
16 25 EC 2
Housing
GD Dose condition No.
17 0 IC 4
17 0 EC 4
17 1 IC 4
17 1 EC 3
17 5 IC 6
17 5 EC 7
17 10 IC 6
17 10 EC 6
17 25 IC 3
17 25 EC 3
Table 1. Experimental design including number of subjects in each treatment
condition.
For each dose, subjects were assigned as littermate pairs, and housing conditions were
balanced for body weight.
Figure 1. Dose–response analysis of MAM on brain size. The relative effects of
prenatal exposure to 0, 1, 5, 10, and 25 mg/kg of MAM are shown in a compari-
son of brains from rats exposed at GD 16 and photographed at weaning. An
enduring reduction in cortical volume was obvious at the highest dose, 25
mg/kg, but was not apparent at lower doses. These defects are most apparent
in the extensive exposure of the subcortical colliculi in the posterior cortex
(arrow), suggesting that the overlying cortex is diminished in size.dams on GD 16 or 17, a time when the super-
ﬁcial cortex is undergoing signiﬁcant develop-
ment. We then screened for enduring defects
when these animals were in late adolescence
(PDs 60–64) using two types of biomarkers.
The ﬁrst biomarker was evidence of persistent
cortical maldevelopment (i.e., an index of deﬁ-
cient morphogenesis). The second biomarker
was the capacity of MAM-exposed cortex to
grow thicker in response to behavioral stimu-
lation (i.e., an index of deficient plasticity).
Because MAM was delivered in utero, it was
possible to compare the relative sensitivities of
these two biomarkers in littermates exposed to
MAM under the same conditions and
assigned randomly to the EC or IC condition.
Statistical analysis revealed a signiﬁcant main
effect of MAM upon cortical thickness
(p < 0.0001), a signiﬁcant main effect of hous-
ing condition upon cortical thickness
(p < 0.0001), and a signiﬁcant main effect of
GD of exposure (p < 0.0001). Signiﬁcant inter-
actions were detected between MAM dose and
housing condition (p < 0.05) and MAM dose
and GD of dose (p < 0.01) but not between
housing condition and GD of dose (p = 0.51).
Disruption of cortical morphogenesis as a
biomarker of prenatal MAM exposure. Upon
weaning, representative brains from litters
exposed at GD 16 were compared (Figure 1).
Visual inspection of these brains confirmed
that the volume of cerebral cortex was reduced
dramatically by a dose of 25 mg/kg, as indi-
cated by the exposed dorsal surface of both
inferior and superior colliculi (Figure 1).
Using these criteria, however, the brains of rats
receiving MAM doses of 1, 5, and 10 mg/kg
were not obviously different from those
exposed to saline vehicle only (0 mg/kg).
Brains of rats exposed to 25 mg/kg MAM on
GD 17 also showed obvious reductions of cor-
tical mass (data not shown). The observation
of microcephaly at the 25 mg/kg dose served
as a positive control for the action of MAM at
lower doses where exposed brains showed no
overt signs of cortical maldevelopment.
For a more ﬁne-grained assessment of mor-
phogenic defects, we measured the overall
thickness of cerebral cortex (Figure 2A). We
sampled thickness in the OC because this
region is appropriate for assessing both defective
morphogenesis (Figure 1) and defective experi-
ence-dependent plasticity. Rats (PDs 60–64)
housed in the IC were used to assess toxicant
effects on thickness of cortex (Figure 2B). A
decrease in cortex was observed in animals
exposed to 25 mg/kg MAM on GD 16 but was
not detected in animals exposed during GD 17.
Taken together with our observations of overall
brain size (Figure 1), these data suggest that ani-
mals exposed to MAM on GD 17 may have
less cortical volume, but the thickness of the
cortex that survives appears to be relatively nor-
mal. Nonetheless, the sensitivity of cortical
mass as a biomarker appears limited to relatively
high dose effects, with a detection threshold in
the present experiment similar to that of previ-
ous reports (Fischer et al. 1972; Haddad et al.
1972; Tamaru et al. 1988).
The capacity for robust plasticity emerges
from healthy development. The usefulness of
experience-dependent plasticity as a bio-
marker hinges on its reliable and robust
induction. Figure 3 demonstrates the stimula-
tory effects of the EC condition (Figure 3A)
compared with housing in the IC condition
(Figure 3B) and shows that the thickness of
the OC is significantly increased after
1 month of exposure to the EC condition.
The mean thickness of cortex was increased
by 18% (p < 0.001; Figure 3C).
Disruption of cortical plasticity as a bio-
marker of prenatal MAM exposure. To deter-
mine if exposure to MAM interfered with this
growth response, we compared differences in
mean cortical thickness between EC and IC
at each dose of MAM (0, 1, 5, 10, and 25
mg/kg). Although signiﬁcant differences were
detected for both main effects of dose and
housing condition with the GLM analysis of
variance, the significant interaction between
environment and MAM dose revealed that
MAM during cortical development altered the
Article | Wallace et al.
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Figure 2. High-dose MAM reduces the baseline thickness of cortex. (A) Cortical thickness measured in a
representative section of OC from a male rat (PD 60–64); the black lines superimposed on the cortex illus-
trate the triplicate thickness measures performed on the section. (B) Quantitative analysis of cortical mea-
surements for male rats (PD 60–64) after exposure to a single dose of saline (0 mg/kg) or MAM (1, 5, 10, or
25 mg/kg) during GD 16 or GD 17 (see “Materials and Methods” for details). Data are reported as mean
thickness for each dose ± SE. 
**p < 0.01.
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Figure 3. OC grows thicker in response to EC. (A) Rats, shown in the play cage, are housed as a group in the EC condition. (B) Their littermates reside individually
in the IC condition. (C) After 28 days of housing in the EC, thickness measurements from the OC of control rats (saline injections) show an increased thickness
compared with their IC siblings; data are reported as mean thickness ± SE.
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capacity for plasticity later in life (Figure 4A,
GD 16; Figure 4B, GD 17). Rats exposed to
the highest dose of MAM (25 mg/kg) failed to
exhibit signiﬁcant increases in cortical thick-
ness in response to the EC condition. Rats
exposed at GD 16, however, showed both a
reduction in baseline thickness of cortex (indi-
cating a morphogenic defect; Figure 2B) and a
reduction in plasticity, whereas rats exposed at
GD 17 showed only reduced plasticity.
A critical test of experience-dependent plas-
ticity as a biomarker of subtle neurotoxic insult
is the comparison between the effects of EC
and IC conditions at low doses of MAM. At
the two lowest doses (1 and 5 mg/kg of MAM),
no basal morphogenic defect was detected
(Figure 2B), but the effect of the EC condition
was blunted or lost (Figure 4). At 1 mg/kg,
the response to the EC condition differed
with GD of exposure; at GD 16 the magni-
tude of response was reduced but still signiﬁ-
cant (p < 0.05; Figure 4A), whereas at GD 17
there was no significant effect of EC (p =
0.23; Figure 4B). At 5 mg/kg, neither the GD
16 nor the GD 17 rats exhibited a signiﬁcant
EC effect (GD 16, p = 0.45; GD 17, p =
0.69). Rats exposed to 10 mg/kg MAM also
failed to show a signiﬁcant effect of EC (GD
16, p = 0.15; GD 17, p = 0.13). The trend for
EC rats to have numerically thicker cortices
than their IC siblings across the 1–10 mg/kg
MAM range suggests that, although reduced
significantly, some capacity for growth may
have been spared.
To determine if exposure to MAM reduced
plasticity in a dose-dependent manner, we
tested the hypothesis that the EC cortices
would decrease in thickness with increased dose
using Jonckheere’s test (Jonckheere 1954).
With this test, the null hypothesis was rejected
both in rats exposed at GD 16 (p < 0.001) and
at GD 17 (p < 0.05). Because these analyses
examined only the differences between EC
groups across doses, we also determined the
correlation of the difference in EC/IC cortical
thickness and dose (Figure 5). For rats treated
with MAM on GD 16, this analysis produced a
correlation coefﬁcient of –0.87 (Figure 5A); for
those exposed on GD 17, the correlation was
–0.63 (Figure 5B). Together, these results 
indicate that as the dose of MAM increased, the
magnitude of the EC response was diminished.
Discussion
The answer to the question of whether the
brain develops normally in the presence of a
toxicant may depend upon on how develop-
ment is measured. One way is use a variety of
sensitive neuropathological techniques to
assess the integrity of neural circuits and asso-
ciated metabolic support at the close of a key
stage (Garman et al. 2001). Here, as an alter-
native way to deﬁne healthy development, we
evaluate experience-dependent plasticity, a late
component of brain development that emerges
after basic circuitry has formed and remains
active into maturity (Black and Greenough
1986). We hypothesized that plasticity would
be a more sensitive biomarker because it
appears to be an emergent integrative property
of a properly assembled brain. The induction
of plasticity depends on a rat’s active explo-
ration of its environment (Ferchmin et al.
1975), and its expression involves changes in
the structure of neurons (Volkmar and
Greenough 1972), glia (Jones et al. 1996;
Sirevaag and Greenough 1991), and blood ves-
sels (Black et al. 1987). The major ﬁnding of
this study was that young adult rats could
appear to have normal cortical thickness after
prenatal exposure to low doses of MAM, yet
exhibit significantly diminished experience-
dependent neuroanatomical plasticity.
The threshold dose of MAM required to
significantly reduce cortical thickness was
clearly > 10 mg/kg, but doses as low as 1 mg/kg
impaired plasticity. This initial assessment of
plasticity as a biomarker demonstrates deﬁcits at
lower prenatal exposures of MAM than have
been documented previously (Ohta et al.
2000). The potential of this model is in its abil-
ity to test the integrity of cellular plasticity
directly under conditions relevant to learning
and memory. Its strength lies in the ability to
detect the expression of experience-dependent
plasticity, as well as the degradation of plastic-
ity by neurotoxic insult, through the use of
within-litter comparisons. In the present study
we did not sample a sufﬁcient number of sub-
jects per dose to fully document the absolute
threshold for disruption of plasticity, nor was
that its intent. Instead, the study was designed
to test the relative sensitivity of this measure
using a well-characterized neurotoxicant.
Although the present data suggest that prenatal
MAM dose and postweaning capacity for
experience-dependent plasticity may be
inversely related (Figure 5), confirmation of
this trend will also require a larger data sample.
Based on this initial study with MAM, we
would not predict that exposure to neur-
toxicants at the low doses of greatest interest
would necessarily eliminate plasticity. In fact,
residual plasticity in the face of toxic insult
Figure 5. The capacity for plasticity is inversely correlated with dose of MAM; the difference between
effects of the EC and IC conditions is plotted by dose for rats exposed to MAM on GD 16 (r = –0.87) (A) and
on GD 17 (r = –0.63) (B). CT, cortical thickness. These plots show a consistent, systematic decline in plas-
ticity, most notably across the low doses (0–5 mg/kg). They also show an unexpected, but consistent,
break in trend at 10 mg/kg. Any exposure to MAM resulted in a diminished plasticity response compared
with that of saline-treated control rats.
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Figure 4. Prenatal MAM exposure impairs postweaning cortical plasticity. OC thickness was measured in
rats exposed to either saline vehicle (0 mg/kg) or MAM (1, 5, 10, or 25 mg/kg) at GD 16 (A) or GD 17 (B) and
housed postweaning in either the EC or the IC condition for 30 days. Plasticity failed at MAM doses below
those required to reduce baseline cortical thickness (compare with Figure 2). Data are reported as mean
thickness ± SE.
*p < 0.05. **p < 0.01.
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10could play an important role in compensating
for brain damage during development and
therefore holds therapeutic promise (Jones et
al. 1998). Remarkable levels of cognitive
function have been reported in individuals
with profound defects in brain morphogene-
sis (Lewin 1980), indicating that the compen-
satory capacity of human developmental
plasticity can be profound under certain con-
ditions. Accordingly, these data suggest that
subtle deﬁcits are likely to show up as quanti-
tative differences in the magnitude of plastic-
ity or in the rate at which it is expressed.
The generality of this model awaits assess-
ment in future studies. The EC paradigm has
proven quite reliable in inducing robust
neuroanatomical plasticity in a variety of
species (Rosenzweig and Bennett 1996) and
appears to represent a fundamental mecha-
nism of brain information storage relevant to
humans (Bertenthal et al. 1984; Karni et al.
1995; Maguire et al. 2000). MAM is a com-
pound that affects the development of cere-
bral cortex directly (Spencer et al. 2000). We
would predict, however, that even if cortical
cells are not damaged directly, cortical plastic-
ity is likely to be vulnerable to disruptions in
the integrity of the extrinsic afferent systems
that trigger it or modulate its expression.
We observed relatively large increases in
cortical thickness of untreated rats after 28
days of the EC condition [e.g., Diamond
(1967)]. However, this analysis may not be
sufficiently sensitive in all species or strains
(e.g., Wainwright et al. 1993), and more
reﬁned assessments of plasticity based speciﬁ-
cally on the growth response of cells may be
required. In species in which both neu-
ropathology can be modeled appropriately and
experience-dependent plasticity induced
robustly, however, the efficiency of a simple
measure of plasticity such as cortical thickness
has tremendous advantages in screening a
large set of toxicants. A testable prediction is
that this paradigm can be applied to a variety
of neurotoxicants to reveal deficits at lower
doses than can routine morphological examina-
tion. If so, this novel biomarker based on expe-
rience-dependent neuroanatomical plasticity
could become an important tool in establishing
limits for acceptable levels of toxicants present
in the environment.
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